Posted in | News | Clean Technology

NanoH2O to Deliver QuantumFlux Membranes to Palmachim Desalination Plant in Israel

NanoH2O Inc., manufacturer of the most efficient and cost-effective reverse osmosis (RO) membranes for seawater desalination, today announced that it has been selected by Via Maris Desalination Ltd. to provide QuantumFlux (Qfx) high rejection membranes for the expansion of the Palmachim desalination plant in Israel. Via Maris Desalination Ltd., owner and operator of the Palmachim plant, purchased QuantumFlux high rejection membranes for an existing 36,000 cubic meter capacity seawater RO train in 2012 and will commission two additional trains in 2013. These three trains will produce a combined total of 110,000 cubic meters of potable water per day.

"After one year of small scale pilot tests and eight months of full scale operation of the initial 36,000 cubic meter per day train, the high rejection QuantumFlux membranes from NanoH2O provided us with the best performance we ever experienced," said Avner Hermony, Palmachim Desalination Plant Manager for Via Maris Desalination, a subsidiary of Global Environmental Solutions (GES). "Given that experience, we will now add two more trains of Qfx membranes by the end of 2013."

"This is a significant milestone for our company," said Nicholas Dyner , Vice President of Sales and Marketing for NanoH2O. "Within a year of our official launch into the membrane desalination market, we have demonstrated impressive acceleration in product development and manufacturing capacity. Palmachim is one of the ten largest seawater RO plants in the world and we are honored to have been chosen as a membrane supplier and to assist Palmachim in their expansion efforts."

Source: http://www.nanoh2o.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.